Skin Care Regimen for Improving Photoaging Signs on the Face

Trial statusNot yet recruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age30-70
SponsorGoldman, Butterwick, Fitzpatrick and Groff

About this trial

Compare the effectiveness of laser treatment using CE Ferulic versus vehicle pre/post laser.

Eligibility criteria

Qualifiers

Adult males and females aged 30-70 years (Fitzpatrick I-IV 30-65 years, Fitzpatrick V-VI 30-70 years)

Fitzpatrick skin types I-VI

Subjects in good general health based on investigator's judgment and medical history

Must be willing to give and sign an informed consent form and photographic release form

Disqualifiers

Energy-based device (i.e., radiofrequency device treatments, microfocused ultrasound device or other ultrasound-based device treatments, laser and light-based device treatments, microneedling) treatment in the treatment area in the last 6 months

Chemical peel or microdermabrasion of the face within 60 days prior to enrollment in the study

Dermal fillers, biostimulators, or neurotoxins treatments of the face during the 6-month period before the study period or planning to undergo during the study period

Surgery (i.e., face lift, eyebrow lift, neck lift or lower rhytidectomy, liposuction to the neck and/or submentum, etc.) during the 12-month period before study treatment

Trial design

Treatments tested in this trial

  • CE Ferulic
  • Sham Comparator
  • 1927nm (Clear and Brilliant Perméa®)

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators